New cancer drug combo enters human testing for Tough-to-Treat tumors
NCT ID NCT06771622
Summary
This early-stage trial is testing a new drug called HCB101 when given alongside other approved cancer treatments. It aims to find a safe and effective dose and see if the combinations can help control advanced solid tumors, including specific types of stomach, breast, and lung cancers. The study will first determine the safest dose and then expand to see how well the treatments work in more people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, China
Conditions
Explore the condition pages connected to this study.